C. difficile management may not be infection control problem

CDC report finds most patients carried bacteria at time of admission

By Healthcare Facilities Today


Standard teaching is that hospital-acquired C. difficile infections (CDI) are an infection control problem, but it may be more closely related to antibiotic control, according to an article posted on Medscape.com.

A recent report from the Centers for Disease Control and Prevention (CDC), showed that 75 percent of the patients were already colonized with C. difficile at the time of admission.

According to the Medscape article, the implication is that to prevent CDI, clinicians need to find ways to identify patients who are already colonized to protect them from obvious risks, and also to consider them to be potential sources of infection to others. This could substantially change infection control practice for prevention of CDI.

Read the article. Note: Registration (free) on Medscape may be required.



September 3, 2013


Topic Area: Safety


Recent Posts

Healthcare Real Estate: Challenges and Industry Shifts for 2025

The hurdles include balancing expansion with financial constraints, the sustainability of office and retail conversions, and technological disruptions.


Geisinger to Build $32 Million Cancer Center in Pennsylvania

The two-story, 40,000-square-foot facility will be home to the cancer center with space for future growth of services.


Sunflower Medical Group Experiences Data Breach

To date, Sunflower has no evidence that personal information has been misused.


Strategies to Eradicate Biofilm Containing C. Auris

Understanding the speed and risks of contamination after room disinfection should inform managers’ environmental cleaning recommendations.


Man Attacks Nurses, Police Officer at Jefferson Hospital

The man allegedly attacked the staff members before being restrained and sedated.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.